- Last Updated: 3/7/2013
TDI 028 (aks TDI-846) may protect motor nerves from further deterioration by reducing inflammation. A monoclonal antibody directed against CD40 ligand, TDI 0028 downregulates the T co-stimulatory pathway, reducing the production of pro-inflammatory cytokines that destroy the motor nerves. CD40 ligand blockers are being developed for a number of conditions including arthritis, multiple sclerosis and cancer.
- Last Updated: 11/23/2011
Isolated originally from the roots of Canadian hemp, apocynin may protect motor nerves from further deterioration by reducing production of damaging reactive oxygen species. Apocynin is also being investigated as a treatment for respiratory diseases such as asthma.
- Last Updated: 1/6/2012
Arimoclomol may reduce the levels of protein aggregates in the motor nerves, a possible cause of ALS, by boosting expression of chaperonins Hsp70 and Hsp90 which help newly synthesized proteins properly fold.
Find this useful?
Help us fund more science:
Hot Topics in Research
A pain reliever for pALS?
The DPS: helping PALS breathe better?
An early treatment for ALS?
What's next after dex?
Could MRI get PALS into trials sooner?
Neuralstem:safe & tolerable?
Exercise: good for PALS?
Why is creating ALS drugs so hard?